Sedative Overdose: Clinical Trials

5 trials for Sedative Overdose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 11Completed 1
Phase 21Completed 1

Follow Sedative Overdose: new trials by email Literature Review of Sedative Overdose trials Research Report on Sedative Overdose

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ARM-ED: Advanced Respiratory Monitoring Events in Drug Toxicity
Pneumowave Device placement and data capture - Respiratory Insufficiency, Overdose of Opiate
CompletedNHS Greater Glasgow and Clyde782022-06-082024-06-21
Local Anesthesia Impact on Dental Sedation
Sedative Overdose
CompletedAnkara University502021-12-012024-01-23
BIS-Guided Sedation in Critically Ill Patients Under Deep Sedation
Monitorization of sedation by Bispectral Index - Delirium, Sedative Overdose
Not applicableUnknownHospital Italiano de Buenos Aires992019-04-012023-08-01
Race-Specific Propofol Titration to Effect for Procedural Sedation
Titrate propofol monotherapy infusion to effect - Unconsciousness, Apnea, Postanesthetic
CompletedUniversity of Florida27802018-01-052019-10-25
Synchronous Effect of Anesthetics on fMRI, EEG and Clinical Responses
Propofol, Remifentanil - Sedative Overdose
Phase 1 / Phase 2CompletedParc de Salut Mar302017-06-132022-09-30

Narrower conditions

Butyrylcholinesterase deficiency (1)  ·  Delirium (1)  ·  Hypoxia (1)  ·  Opiate Overdose (1)  ·  Respiratory Insufficiency (1)  ·  Unconsciousness (1)

Broader conditions

Mental Disorders (2)  ·  Nervous System Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Chemically-Induced Disorders (1)  ·  Confusion (1)  ·  Consciousness Disorders (1)  ·  Drug Misuse (1)  ·  Drug Overdose (1)  ·  Narcotic-Related Disorders (1)  ·  Neurocognitive Disorders (1)  ·  Opioid-Related Disorders (1)  ·  Prescription Drug Misuse (1)

Interventions

Propofol (1)  ·  Remifentanil (1)

Sponsors

Ankara University (1)  ·  Hospital Italiano de Buenos Aires (1)  ·  NHS Greater Glasgow and Clyde (1)  ·  Parc de Salut Mar (1)  ·  University of Florida (1)

Countries

Argentina (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

David J Lowe, MBChB BMSc FRCEM (1)  ·  Federico Carini, MD (1)  ·  Ivan A. Huespe, MD (1)  ·  Jeffrey White, MD (1)  ·  Sergio Giannasi, MD (1)

Results publications

PMID 38901489, PMID 41855476

NIH funding

UL1TR001427 (1)